Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting : JCR: Journal of Clinical Rheumatology

Secondary Logo

Journal Logo

Concise Reports

Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting

Kotecha, Jalpa MRCP; Fardeen, Kazi Mashfia MBBS; Mirzazadeh, Mehdi MRCP, FRCPath

Author Information
JCR: Journal of Clinical Rheumatology 29(2):p 101-104, March 2023. | DOI: 10.1097/RHU.0000000000001894
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid